Zydus Cadila gets USFDA approval to market 2 drugs
Zydus Cadila has received final approval to market two drugs, from the US health regulator. The company stated that, it has received approval to market Methylprednisolone tablets USP...
Tag : Gets
Nazara Technologies gets Sebi’s approval to float IPO
Nazara Technologies has received Sebi’s approval, to float an initial public offering (IPO). This is a mobile gaming company and is popular for its games...
Zydus gets USFDA approval to market Diclofenac Sodium Topical Solution
Zydus Cadila has received final approval to market Diclofenac Sodium Topical Solution, from the US health regulator. It is used for treating signs and symptoms of osteoarthritis of...
Glenmark gets USFDA approval for skin ointment
Glenmark Pharmaceuticals has received final approval for Tacrolimus ointment, from the US health regulator. The ointment is used for treating atopic dermatitis (eczema). In a BSE...
Dilip Buildcon gets provisional completion certificate in Karnataka
Dilip Buildcon has been issued provisional completion certificate, for highway project in Karnataka. It has informed that project WCP-6 DBFOMT of existing state highway Mundargi-Hadagali-Harapanhalli, Karnataka,...
Navkar Corporation gets NCLT nod for amalgamation of Navkar Terminals
Navkar Corporation has received green signal from NCLT, for amalgamation of Navkar Terminals with the company. Navkar Terminals is the wholly owned subsidiary of the...
Biocon gets marketing authorization approval from European Commission
Biocon has received marketing authorization from the European Commission. Mylan N. V. and Biocon declared that their co-developed biosimilar insulin glargine Semglee, has received marketing authorization...
Strides Shasun gets NCLT nod for scheme of arrangement
The National Company Law Tribunal, Mumbai Bench (NCLT) vide its order dated March 9,2018, issue on March 22,2018 has approved the composite scheme of arrangement....
Bandhan Bank gets Sebi approval for Rs.2,500 crore IPO
Bandhan Bank, has received Sebi’s approval to raise approx Rs.2,500 crore via an initial share sale. The bank had filed draft papers with Sebi on...
Laurus Labs gets zero observations from USFDA
Laurus Labs has received Form 483 with zero observations for Unit 2 (the formulations unit). The United States Food and Drug Administration (USFDA) has successfully...